An in silico and in vitro human neuronal network model reveals cellular mechanisms beyond NaV1.1 underlying Dravet syndrome
Stem Cell Reports · 2023-08 · 18 (8) · 1686-1700
DOI: 10.1016/j.stemcr.2023.06.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2023-08. Verfasst von Nina Doorn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurophysiology, University of Twente, 7522 NB Enschede, the Netherlands. Electronic address: n.doorn-1@utwente.nl. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Epilepsies, Myoclonic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
Human induced pluripotent stem cell (hiPSC)-derived neuronal networks on multi-electrode arrays (MEAs) provide a unique phenotyping tool to study neurological disorders. However, it is difficult to infer cellular mechanisms underlying these phenotypes. Computational modeling can utilize the rich dataset generated by MEAs, and advance understanding of disease mechanisms. However, existing models lack biophysical detail, or validation and calibration to relevant experimental data. We developed a biophysical in silico model that accurately simulates healthy neuronal networks on MEAs. To demonstrate the potential of our model, we studied neuronal networks derived from a Dravet syndrome (DS) patient with a missense mutation in SCN1A, encoding sodium channel NaV1.1. Our in silico model revealed that sodium channel dysfunctions were insufficient to replicate the in vitro DS phenotype, and predicted decreased slow afterhyperpolarization and synaptic strengths. We verified these changes in DS patient-derived neurons, demonstrating the utility of our in silico model to predict disease mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neurophysiology, University of Twente, 7522 NB Enschede, the Netherlands. Electronic address: n.doorn-1@utwente.nl.
- Department of Neurology, Academic Center for Epileptology Kempenhaeghe, 5591 VE Heeze, the Netherlands; Department of Human Genetics, Radboudumc, 6500 HB Nijmegen, the Netherlands; Department of Cognitive Neurosciences,…
- Department of Human Genetics, Radboudumc, 6500 HB Nijmegen, the Netherlands; Department of Cognitive Neurosciences, Radboudumc, Donders Institute for Brain Cognition and Behaviour, 6525 HR Nijmegen, the Netherlands.
- Department of Applied Mathematics, University of Twente, 7522 NB Enschede, the Netherlands.
- Department of Clinical Neurophysiology, University of Twente, 7522 NB Enschede, the Netherlands.
- Department of Clinical Neurophysiology, University of Twente, 7522 NB Enschede, the Netherlands; Department of Neurology and Clinical Neurophysiology, Medisch Spectrum Twente, 7512 KZ Enschede, the Netherlands.
Förderung
- ZonMw
Zitieren
APA
Doorn, N., van Hugte, E. J. H., Ciptasari, U., Mordelt, A., Meijer, H. G. E., Schubert, D., Frega, M., Nadif Kasri, N., & van Putten, M. J. A. M. (2023). An in silico and in vitro human neuronal network model reveals cellular mechanisms beyond NaV1.1 underlying Dravet syndrome. Stem Cell Reports, 18(8), 1686-1700. https://doi.org/10.1016/j.stemcr.2023.06.003
Vancouver
Doorn N, van Hugte EJH, Ciptasari U, Mordelt A, Meijer HGE, Schubert D, et al. An in silico and in vitro human neuronal network model reveals cellular mechanisms beyond NaV1.1 underlying Dravet syndrome. Stem Cell Reports. 2023;18(8):1686-1700. doi:10.1016/j.stemcr.2023.06.003
BibTeX
@article{Doorn2023,
author = {Doorn, Nina and van Hugte, Eline J H and Ciptasari, Ummi and Mordelt, Annika and Meijer, Hil G E and Schubert, Dirk and Frega, Monica and Nadif Kasri, Nael and van Putten, Michel J A M},
title = {An in silico and in vitro human neuronal network model reveals cellular mechanisms beyond NaV1.1 underlying Dravet syndrome},
journal = {Stem Cell Reports},
year = {2023},
volume = {18},
number = {8},
pages = {1686--1700},
doi = {10.1016/j.stemcr.2023.06.003}
}
EUVIMED